Notably, increases in the FSH changes by menopausal stage are positively associated with higher adiponectin concentrations [14], suggesting that FSH might be linked to aspects of adipocyte-derived factors, metabolic disorder, and insulin resistance. This evidence concerns the gene BRD2 and metabolic disease.